J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leren, T. P.
Right arrow Articles by von Eckardstein, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leren, T. P.
Right arrow Articles by von Eckardstein, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 38, 121-131, Copyright © 1997 by Lipid Research, Inc.


ARTICLES

Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A- II but normal levels of HDL-subclass LpA-I

TP Leren, KS Bakken, U Daum, L Ose, K Berg, G Assmann and A von Eckardstein
Department of Medical Genetics, Ullevaal University Hospital, Oslo, Norway.

We studied a Norwegian patient and his family, who presented with low HDL-cholesterol. DNA sequence analysis of the apoA-I gene revealed heterozygosity for a mutation in the apoA-I gene that causes a leucine for arginine replacement at residue 160. Compared to unaffected family members, heterozygous carriers of apoA-1 (R160L)Oslo had 60-70% lower mean levels of HDL-cholesterol, 50-60% lower mean levels of apoA-I and 70-80% lower levels of apoA-II. Moreover, the serum concentration of the apoA-II-containing HDL-subclass LpA-I/A-II was decreased by 70% whereas the concentration of the apoA-II-free HDL-subclass LpA-I did not differ from that in unaffected family members. The decrease of LpA- I/A-II was associated with the lack of large LpA-I/A-II. ApoA- I(R160L)Oslo was present at increased concentrations relative to normal apoA-I in plasma, HDL3, and LpA-I. However, only trace amounts of the variant isoform were detectable in immunopurified LpA-I/A-II. Pre beta1- LpA-I contained normal and variant apoA-I isoforms. We conclude that the failure of apoA-I(R160L)Oslo to form LpA-I/A-II causes low HDL- cholesterol in heterozygous carriers of this apoA-I variant.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
J. M. Martin-Campos, J. Julve, J. C. Escola, J. Ordonez-Llanos, J. Gomez, J. Binimelis, F. Gonzalez-Sastre, and F. Blanco-Vaca
ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia
J. Lipid Res., January 1, 2002; 43(1): 115 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K.-H. Cho, D. M. Durbin, and A. Jonas
Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements
J. Lipid Res., March 1, 2001; 42(3): 379 - 389.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
P. G. Frank and Y. L. Marcel
Apolipoprotein A-I: structure;-function relationships
J. Lipid Res., June 1, 2000; 41(6): 853 - 872.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. G. Sorci-Thomas, M. Thomas, L. Curtiss, and M. Landrum
Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice
J. Biol. Chem., April 14, 2000; 275(16): 12156 - 12163.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Han, J. Sasaki, A. Matsunaga, H. Hakamata, W. Huang, M. Ageta, T. Taguchi, T. Koga, M. Kugi, S. Horiuchi, et al.
A Novel Mutant, ApoA-I Nichinan (Glu235->0), Is Associated With Low HDL Cholesterol Levels and Decreased Cholesterol Efflux From Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1447 - 1455.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
U. Daum, T. P. Leren, C. Langer, A. Chirazi, P. Cullen, P. H. Pritchard, G. Assmann, and A. von Eckardstein
Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
J. Lipid Res., March 1, 1999; 40(3): 486 - 494.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Huang, J. Sasaki, A. Matsunaga, H. Nanimatsu, K. Moriyama, H. Han, M. Kugi, T. Koga, K. Yamaguchi, and K. Arakawa
A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency
Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 389 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Durbin and A. Jonas
The Effect of Apolipoprotein A-II on the Structure and Function of Apolipoprotein A-I in a Homogeneous Reconstituted High Density Lipoprotein Particle
J. Biol. Chem., December 12, 1997; 272(50): 31333 - 31339.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. E. Miettinen, M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula
Apolipoprotein A-IFIN (Leu159->Arg) Mutation Affects Lecithin : Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3021 - 3032.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.